Work

866 Preclinical Study of Pamiparib, a CNS Penetrant PARP Inhibitor, in IDH1/2 Mutated Gliomas

Year: 2023

Type: article

Source: Neurosurgery

DOI: 10.1227/neu.0000000000002375_866

Authors: Christopher Sungwoon Hong, Ranjini Sundaram, Ranjit Bindra

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4327608409

FWCI:

Cites:

Cited by:

Related to: 10